Allergan reaches a settlement with InnoPharma, a subsidiary of Pfizer on Restasis patent. Out of the four contestants, Mylan, Teva and Akorn are still contesting the patents in the federal court. http://alph.st/b3437240
I see this as somewhat good news for Allergan and bad news for Mylan, Teva, etc. If their case for overturning the patents was that strong then Innopharma would not have been willing to make a deal.
